Boston-based private investment firm SV Health Investors (SVHI) announces an investment in Grand Rapids-based Packaging Compliance Labs (PCL), a provider of healthcare packaging engineering, validation testing, and contract packaging services to the medical device and pharmaceutical end markets.<\/p>\n\n\n\n
Founded in 2014, Packaging Compliance Labs is a leading sterile packaging center of excellence, providing comprehensive healthcare packaging solutions aimed to accelerate medical device and pharmaceutical product launches. PCL’s extensive capabilities support customers in each step of packaging from the design phase to full-scale production.<\/p>\n\n\n\n
PCL represents a new platform investment for SV Health Investors, in partnership with Co-Founders Matthew Lapham and Ryan Erickson.<\/p>\n\n\n\n
A.J. Rossi, Principal at SV Health Investors, who will join the PCL board of directors, stated, “PCL has developed an industry-leading reputation for white-glove technical testing services, while serving as a thought leader within the healthcare packaging industry. We look forward to partnering with PCL to support their continued growth through investment in rapidly expanding operations and strategic add-on acquisitions.” Matthew Lapham, President & CEO of Packaging Compliance Labs, added, “PCL is excited to accelerate our growth together with SV Health Investors. SV’s extensive industry experience and strong operational resources will be an asset to PCL as we continue to scale and provide timely, expert solutions to our clients.”<\/p>\n\n\n\n
The investment in Packaging Compliance Labs aligns with SVHI’s model of partnering with founders and entrepreneurs to build industry-leading healthcare services businesses. Greg Madden, SVHI Managing Partner, and Thomas Patton, SVHI Operating Partner, will also join the board.<\/p>","protected":false},"excerpt":{"rendered":"
Packaging Compliance Labs is a provider of healthcare packaging engineering, validation testing, and contract packaging services to the medical device and pharmaceutical end markets<\/p>","protected":false},"author":2,"featured_media":23457,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"colormag_page_layout":"default_layout","footnotes":""},"categories":[7,682,10],"tags":[594],"class_list":["post-17376","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-americas","category-design-manufacturing","category-strategic-development","tag-financing"],"_links":{"self":[{"href":"https:\/\/g-medtech.com\/news\/fr\/wp-json\/wp\/v2\/posts\/17376","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/g-medtech.com\/news\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/g-medtech.com\/news\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/g-medtech.com\/news\/fr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/g-medtech.com\/news\/fr\/wp-json\/wp\/v2\/comments?post=17376"}],"version-history":[{"count":3,"href":"https:\/\/g-medtech.com\/news\/fr\/wp-json\/wp\/v2\/posts\/17376\/revisions"}],"predecessor-version":[{"id":38163,"href":"https:\/\/g-medtech.com\/news\/fr\/wp-json\/wp\/v2\/posts\/17376\/revisions\/38163"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/g-medtech.com\/news\/fr\/wp-json\/wp\/v2\/media\/23457"}],"wp:attachment":[{"href":"https:\/\/g-medtech.com\/news\/fr\/wp-json\/wp\/v2\/media?parent=17376"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/g-medtech.com\/news\/fr\/wp-json\/wp\/v2\/categories?post=17376"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/g-medtech.com\/news\/fr\/wp-json\/wp\/v2\/tags?post=17376"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}